Acquisition of UF Faculty Startup AbFero Provides Iron Chelators for Numerous Diseases
Late last week, Danish biotech Pharmacosmos announced it had acquired AbFero Pharmaceuticals, a University of Florida startup, for $225 million. AbFero is developing compounds called iron chelators created in Dr. Raymond Bergeron’s lab at UF. Chelators remove extra iron from the body.
UF Innovate | Ventures Invests in AbFero Pharmaceuticals
The University of Florida’s newly established venture fund, directed by UF Innovate | Ventures, has invested part of its inaugural fund in AbFero Pharmaceuticals, Inc. UF Innovate Ventures is acting as a follow-on investor to the lead investor Longwall Ventures from the United Kingdom. AbFero’s therapeutic platform addresses transfusion-related iron overload and iron accumulation associated […]